Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge ...

Diversity in clinical trials can positively impact patient care and outcomes, particularly among minority populations, Anita ...

Scientists and doctors remain divided on the targeted antibody drugs that slow down the early stages of Alzheimer’s ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

Surya Gummadi, president of Cognizant Americas, discusses the transformative impact of AI in health care, emphasizing ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have ...

The National Institute for Health and Care Excellence (NICE) has today issued final decisions on lecanemab and donanemab, ...

Catching the flu or COVID can trigger a heart attack or stroke in vulnerable people. Here’s what we can all do to lower our ...

Knowable Magazine shares how studies show psychological strain can accelerate tumors and asks if beta blockers slow them down ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

Dr. Bruce Chabner explains how clinical trials pave the way for new treatments and the benefits of participating in one.